IgE Depletion with Ligelizumab Does Not Significantly Improve Clinical Symptoms in Patients with Moderate-to-Severe Atopic Dermatitis
Christine Bangert, Christian Loesche, Hans Skvara, Regina Fölster‐Holst, J.‐P. Lacour, Julie Jones, Patrick Burnett, Natalija Novak, Georg Stingl
Topics & Concepts
OmalizumabImmunoglobulin EAtopic dermatitisMedicinePlaceboEczema Area and Severity IndexImmunologyRandomized controlled trialClinical trialInternal medicineAntibodyGastroenterologyPathologyAlternative medicineDermatology and Skin DiseasesUrticaria and Related ConditionsAllergic Rhinitis and Sensitization